^“Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase”. Proceedings of the National Academy of Sciences of the United States of America94 (10): 4884–9. (May 1997). Bibcode: 1997PNAS...94.4884R. doi:10.1073/pnas.94.10.4884. PMC 24600. PMID (9144159). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24600/.
^“EEF2K Gene (Protein Coding)”. GeneCards. Weizmann Institute of Science. 2015年11月4日閲覧。
^“Phosphorylation of elongation factor 2: a key mechanism regulating gene expression in vertebrates”. The New Biologist2 (10): 843–50. (Oct 1990). PMID (1964087).
^ ab“Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence”. Biochemistry51 (11): 2232–45. (Mar 2012). doi:10.1021/bi201788e. PMC 3401519. PMID (22329831). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401519/.
^ ab“The molecular mechanism of eukaryotic elongation factor 2 kinase activation”. The Journal of Biological Chemistry289 (34): 23901–16. (Aug 2014). doi:10.1074/jbc.m114.577148. PMC 4156036. PMID (25012662). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156036/.
^“The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine”. Biological Psychiatry73 (12): 1199–203. (Jun 2013). doi:10.1016/j.biopsych.2012.09.006. PMC 3574622. PMID (23062356). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574622/.
^“Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.”. PLOS ONE7 (7): e41171. (Mar 20, 2012). Bibcode: 2012PLoSO...741171T. doi:10.1371/journal.pone.0041171. PMC 3401164. PMID (22911754). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401164/.
^“Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.”. Apoptosis19 (1): 241–58. (Jan 22, 2014). doi:10.1007/s10495-013-0927-2. PMID (24193916).
関連文献
“Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2”. The Journal of Biological Chemistry262 (36): 17299–303. (Dec 1987). doi:10.1016/S0021-9258(18)45377-X. PMID (3693353).
“Regulation of elongation factor-2 by multisite phosphorylation”. European Journal of Biochemistry213 (2): 689–99. (Apr 1993). doi:10.1111/j.1432-1033.1993.tb17809.x. PMID (8386634).
“Mapping the functional domains of elongation factor-2 kinase”. Biochemistry39 (40): 12216–24. (Oct 2000). doi:10.1021/bi0007270. PMID (11015200).
“Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity”. The Biochemical Journal353 (Pt 3): 621–6. (Feb 2001). doi:10.1042/0264-6021:3530621. PMC 1221608. PMID (11171059). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221608/.
“A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta”. The EMBO Journal20 (16): 4360–9. (Aug 2001). doi:10.1093/emboj/20.16.4360. PMC 125581. PMID (11500363). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125581/.
“Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus”. Biochemical and Biophysical Research Communications293 (3): 1073–6. (May 2002). doi:10.1016/S0006-291X(02)00324-8. PMID (12051769).
“Expressed sequence tag analysis of human RPE/choroid for the NEIBank Project: over 6000 non-redundant transcripts, novel genes and splice variants”. Molecular Vision8: 205–20. (Jun 2002). PMID (12107410).
“Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways”. The Biochemical Journal367 (Pt 2): 525–32. (Oct 2002). doi:10.1042/BJ20020916. PMC 1222910. PMID (12171600). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1222910/.
“Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398”. The Journal of Biological Chemistry279 (13): 12220–31. (Mar 2004). doi:10.1074/jbc.M309773200. PMID (14709557).
“A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin”. Molecular and Cellular Biology24 (7): 2986–97. (Apr 2004). doi:10.1128/MCB.24.7.2986-2997.2004. PMC 371112. PMID (15024086). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC371112/.
“Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry”. Analytical Chemistry76 (10): 2763–72. (May 2004). doi:10.1021/ac035352d. PMID (15144186).
“Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain”. The FEBS Journal272 (16): 4211–20. (Aug 2005). doi:10.1111/j.1742-4658.2005.04833.x. PMID (16098202).
“Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes”. Genome Research16 (1): 55–65. (Jan 2006). doi:10.1101/gr.4039406. PMC 1356129. PMID (16344560). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356129/.
“Elongation factor-2 kinase: its role in protein synthesis and autophagy”. Autophagy2 (4): 294–6. (2007). doi:10.4161/auto.2857. PMID (16921268).
“A probability-based approach for high-throughput protein phosphorylation analysis and site localization”. Nature Biotechnology24 (10): 1285–92. (Oct 2006). doi:10.1038/nbt1240. PMID (16964243).
“Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell127 (3): 635–48. (Nov 2006). doi:10.1016/j.cell.2006.09.026. PMID (17081983).